Roundup: Indian startups rating new fundings and extra briefs

Ayurveda tech startup NirogStreet snaps up $12M in Sequence B funding

NirogStreet, an Ayurveda know-how platform in India, has scored $12 million in a Sequence B funding spherical led by Jungle Ventures.

It supplies a neighborhood for Ayurveda medical doctors and an e-commerce platform that streamlines the provision chain of Ayurvedic providers and drugs. NirogStreet has onboarded round 50,000 medical practitioners and about 50 Ayurveda manufacturers.

The startup will use the proceeds from its newest investing spherical to bolster its provide chain, know-how, and providers. 

Males’s well being startup Bonatra obtains pre-seed funding

Bonatra, a males’s health-focused startup from India, has raised INR 55 million ($670,000) in a pre-seed funding spherical led by ITI Development Alternatives Fund with the participation of marquee angel traders, Jitendra Jagadev, founding father of Nestaway, and Blackbuck founder Rajesh Yabaji. 

The corporate runs a know-how platform that provides personalised well being programmes focusing on continual circumstances of males.

In a press release, Bonatra stated that its contemporary funds can be used to broaden its choices, construct its group, and develop its consumer base.

Edenlux introduces AI report back to its cell eye well being app

South Korean medical gadget maker Edenlux is now offering AI-generated eye well being administration stories by its flagship cell app Otus Plus. 

The app permits customers to check their eye well being with a paired goggle gadget, do gamified eye workouts, and obtain an eye fixed well being report.

Its eye well being stories now comprise AI-generated eye well being scores, evaluation of eye focus response velocity, and outcomes of eye train video games primarily based on customers’ knowledge. 

Sooner or later, Edenlux plans so as to add an enchancment indicator to its stories, in addition to provide a service that permits customers to decide on their very own customised lenses for eye workouts and use amassed knowledge to offer an eye fixed well being rating report.

Cha Vaccine ties up with MOGAM for AI drug discovery

The MOGAM Institute for Biomedical Analysis has signed a memorandum of understanding with the Cha Vaccine Institute for AI drug discovery.

They may cooperate to develop new medication and enhance drug substances utilizing MOGAM’s AI algorithms, which can be examined utilizing medical knowledge from Cha Vaccine. Later, they are going to conduct joint research and apply for co-patents.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles